Key Features

  • Features a standardized format throughout to facilitate quick access to information
  • Makes a clear distinction between the characteristics of screening tests versus diagnostic tests
  • Offers recommendations regarding the usefulness and acceptability of testing and preventative measures for both established and emerging settings
  • Includes expanded coverage of large screening tests for Down Syndrome and cystic fibrosis

Table of Contents

1 Epidemiologic Considerations in Screening
2 Maternal Red Blood Cell Group and Antibody Screen
3 Antepartum Assessment of Hemoglobin, Hematocrit, and Serum Ferritin
4 Postpartum Assessment of Hemoglobin, Hematocrit, and Serum Ferritin
5 Asymptomatic Bacteriuria in Pregnancy
6 Neonatal Group B Streptococcal Disease
7 Rubella During Pregnancy
8 Congenital Toxoplasmosis
9 Congenital Cytomegalovirus Infection
10 Hepatitis A, B, and C During Pregnancy
11 Syphilis
12 Gonorrhea
13 Chlamydial Infection
14 HIV Infection
15 Screening for Cystic Fibrosis Carrier Status
16 Screening for Hemoglobinopathies
17 Early-onset Genetic Disease
18 Screening for Fragile X Syndrome
19 Screening for Huntington Disease
20 Routine Ultrasound for Dating
21 First Trimester Screening for Aneuploidy
22 Second Trimester Screening for Aneuploidy (Ultrasound and Biochemistry)
23 Biochemical Screening for Fetal Abnormalities
24 Routine Ultrasonography for the Detection of Fetal Structural Anomalies
25 Molecular Tests for Antenatal Detection of Aneuploidy
26 Thrombophilia and Pregnancy Complications: Preeclampsia, (Late) Intrauterine Fetal Death, and Thrombosis
27 Screening for Autoimmune Diseases in Pregnancy
28 Gestational Diabetes Mellitus
29 Screening for Low Birth Weight Using Maternal Height and Weight
30 Fundal Height Measurement
31 Fetal Growth Restriction
32 Doppler Velocimetry for the Detection of Intrauterine Growth Restriction
33 Preterm Delivery
34 Preeclampsia: Blood Pressure, Weight Gain, and Edema
35 Uterine Artery Doppler as Screening Tool for Preeclampsia
36 Preeclampsia and Uric Acid
37 Fetal Hypoxia
38 Peripartum Coagulopathy
39 Postpartum Umbilical Cord Blood Testing
40 When to Screen for Neonatal Hypoglycemia
41 Neonatal Hyperbilirubinemia
42 Screening for Neonatal Genetic Disorders
43 The Annual Bimanual Examination
44 Dyslipidemia
45 D

Details

No. of pages:
704
Language:
English
Copyright:
© 2006
Published:
Imprint:
Saunders
Print ISBN:
9781416003007
Electronic ISBN:
9781416064046

About the authors

Tim Peters

Professor Peters is a statistician by background, with an interest and track record in risk assessment that commenced with his PhD in the field of perinatal and paediatric epidemiology undertaken at the University of Exeter about 20 years ago. His interests evolved into primary care research in general, and randomised trials in particular (including issues of cancer treatment and screening) during a series of academic posts first at Cardiff and, since 1992, at the University of Bristol. He is a member of the NCRI Palliative Care Clinical Studies Development Group, and is Director of the NCRI-accredited Bristol Randomised Trials Collaboration. He has extensive experience on regional and national grants committees, including the NHS Health Technology Assessment Commissioning Board and the MRC Health Services and Public Health Research Board. He is a member of the Primary Care and Other Community Based Subjects panel for the 2008 Research Assessment Exercise, is a co-editor of the journal Paediatric and Perinatal Epidemiology and is on the Editorial Board of the British Journal of General Practice. Professor Peters has ongoing interest in communicating statistical methods and the results of complex research designs and data analyses to a general clinical audience. He is an author of over 200 peer-reviewed publications, on two occasions winning the RCGP/Boots the Chemists Research Paper of the Year Award. He has co-edited the book ‘Screening in Obstetrics and Gynecology’, which has recently been extensively revised in a second edition.